Arkolith/Insider Trading/AARD/Form 4

Lee Tien-Li

Chief Executive Officer, Director, 10% OwnerAardvark Therapeutics, Inc. (AARD) · full profile →Form 4 · filed Aug 29, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 28, 2025Option exercise(M)17K$4.24$73K1.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 28, 2025Option exercise(M)17K—$042K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-192747) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML